Evidence that partly supports the condition
The recurring-revenue base accelerated at the end of the year.
Organic ASV rose $168.2m year over year to $2.568bnQ4 organic revenue grew 7.1%, annual retention remained above 95%, and AI solutions ASV added during FY2026 more than doubled year over year. Those facts support the view that commercial demand is improving rather than merely being acquired.
Evidence that can still overturn it
Higher growth has not yet restored the incremental margin.
FY2026 adjusted operating margin: 34.5%, down 180 bpsQ4 adjusted operating margin was 33.0%, down 80 basis points, with ASV-linked incentive plans and technology expense cited as pressure. FY2027 guidance calls for 5.0%–6.5% organic ASV growth, so the next proof is whether the business can protect profitability while that growth normalizes.